1 From the Department of Medicine, Wayne State University School of Medicine, Detroit, Michigan.
The action of sublingual nitroglycerin (0.6 mg) and intravenous propranolol (0.1 mg/kg) on shortening of right ventricular fibers was investigated in patients with and without coronary artery disease. This was accomplished with a newly devised strain gauge catheter. Hemodynamic parameters and changes in the oxidation-reduction potential of heart muscle were determined. Nitroglycerin results in decrease in shortening and velocity of shortening of ventricular fibers, heart rate, left ventricular end-diastolic and systemic pressure, dp/dt, tension-time index, stroke index, peripheral resistance, and left ventricular minute work in normal and arteriosclerotic subjects. Intravenous propranolol leads to a fall in velocity of shortening of myocardial fibers, heart rate, dp/dt, stroke index, and left ventricular minute work. However, there is an increase in tension-time index and peripheral resistance with no change in systemic pressure. Left ventricular end-diastolic pressure rises significantly in arteriosclerotic patients. The myocardial oxidation-reduction potential increases after nitroglycerin whereas it falls after propranolol in normal and arteriosclerotic patients.
© 1967 American Heart Association, Inc.
A Comparative Study of Nitroglycerin and Propranolol
Key Words: Hemodynamics Lactic-pyruvic acid ratio Velocity of fiber shortening Oxidation-reduction potential
This article has been cited by other articles:
![]() |
C. R. Cooke, B. M. Wall, K. M. Huch, and T. Mangold Cardiovascular effects of vasopressin following V1 receptor blockade compared to effects of nitroglycerin Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R887 - R893. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. LEIER, N. D. BAKER, and P. A. WEBER Cardiovascular Effects of Ophthalmic Timolol Ann Intern Med, February 1, 1986; 104(2): 197 - 199. [Abstract] [PDF] |
||||
![]() |
E. A. Amsterdam and D. T. Mason Hemodynamic Factors and Indirect Assessment of Myocardial Oxygen Consumption in the Therapy of Angina Pectoris Angiology, December 1, 1977; 28(12): 844 - 852. [PDF] |
||||
![]() |
J. N. COHN, K. J. MATHEW, J. A. FRANCIOSA, and J. A. SNOW Chronic Vasodilator Therapy in the Management of Cardiogenic Shock and Intractable Left Ventricular Failure Ann Intern Med, December 1, 1974; 81(6): 777 - 780. [Abstract] [PDF] |
||||
![]() |
S. E. EPSTEIN, D. R. REDWOOD, R. E. GOLDSTEIN, G. D. BEISER, D. R. ROSING, D. L. GLANCY, R. L. REIS, and E. B. STINSON Angina Pectoris: Pathophysiology, Evaluation, and Treatment Ann Intern Med, August 1, 1971; 75(2): 263 - 296. [Abstract] [PDF] |
||||
![]() |
T. T. Zsoter and D. S. Beanlands Propranolol in Angina Pectoris Arch Intern Med, November 1, 1969; 124(5): 584 - 587. [Abstract] [PDF] |
||||
![]() |
E. A. Amsterdam, R. Gorlin, and S. Wolfson Evaluation of Long-Term Use of Propranolol in Angina Pectoris JAMA, October 6, 1969; 210(1): 103 - 106. [Abstract] [PDF] |
||||
![]() |
R. J. Bing, C. Cowan, D. Bottcher, G. Corsini, and C. G. Daniels A New Method of Measuring Coronary Blood Flow in Man JAMA, July 29, 1968; 205(5): 277 - 280. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1967 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |